Knight Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 13.13% vs 21.91% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 69.84% vs -672.73% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.50",
          "val2": "107.40",
          "chgp": "13.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.40",
          "val2": "8.50",
          "chgp": "116.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "2.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.60",
          "val2": "-5.70",
          "chgp": "19.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.80",
          "val2": "-12.60",
          "chgp": "69.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.30%",
          "val2": "-34.20%",
          "chgp": "3.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.13% vs 11.78% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 125.60% vs 43.81% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "371.30",
          "val2": "328.20",
          "chgp": "13.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.60",
          "val2": "56.80",
          "chgp": "6.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "12.50",
          "chgp": "-26.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.60",
          "val2": "-13.50",
          "chgp": "14.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.30",
          "val2": "-16.80",
          "chgp": "125.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.20%",
          "val2": "19.60%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

121.50

107.40

13.13%

Operating Profit (PBDIT) excl Other Income

18.40

8.50

116.47%

Interest

2.40

2.40

Exceptional Items

-4.60

-5.70

19.30%

Consolidate Net Profit

-3.80

-12.60

69.84%

Operating Profit Margin (Excl OI)

5.30%

-34.20%

3.95%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 13.13% vs 21.91% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 69.84% vs -672.73% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

371.30

328.20

13.13%

Operating Profit (PBDIT) excl Other Income

60.60

56.80

6.69%

Interest

9.20

12.50

-26.40%

Exceptional Items

-11.60

-13.50

14.07%

Consolidate Net Profit

4.30

-16.80

125.60%

Operating Profit Margin (Excl OI)

20.20%

19.60%

0.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 13.13% vs 11.78% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 125.60% vs 43.81% in Dec 2023

All Annual Results